Nipro Corp (8086)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Nipro Corp (8086) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011072
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nipro Corp (Nipro) manufactures, develops and markets pharmaceutical, medical and glass products. The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary products, double bags, pre-filled syringes, half-type kits among others. It offers contract manufacturing services in various dosage forms, including injectables, external preparations, orally administerd drugs and primary-packaging pharmaceutical containers. Nipro also provides glass molding vials, ampoules, syringes, and cartridges; glass tubes for pharmaceuticals; glass forming machinery; other parts of pharmaceutical packaging including rubber plugs; and glass bulbs for vacuum flasks. The company has its factories and sales offices across North America, South America, Europe, Asia, and Africa regions. Nipro is headquartered in Osaka, Japan.

Nipro Corp (8086) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nipro Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Nipro Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Nipro Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Nipro Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Nipro Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Nipro Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Nipro Invests US$25 Million In Infraredx 10
InfraReDx Secures US$24.1 Million In Financing 11
Biocept Raises Funds In Growth Equity Financing Round 12
Partnerships 13
Rontis Enters into Distribution Agreement with Nipro Medical 13
Infraredx Enters into R&D Agreement with Massachusetts General Hospital 14
Koninklijke Royal Philips And Infraredx Enter Into Agreement For Imaging System And X-ray Systems 15
Infraredx Enters Into Co-Development Agreement With Philips 16
Infraredx Enters Into Distribution Agreement With Nipro For TVC Imaging System 17
Nipro To Form A Joint Venture With Freesom Holdings 18
Equity Offering 19
Infraredx Withdraws IPO 19
Biocept Raises USD2 Million in Private Placement of Series A Preferred Stock 20
Nipro Completes Public Offering Of Shares For US$266 Million 21
Nipro Prices Private Placement Of Shares For US$31 Million 22
Debt Offering 23
Nipro Announces Private Placement Of Convertible Bonds For US$85.5 Million 23
NIPRO Completes Private Placement Of Eights Series Unsecured Straight Bonds For US$244 Million 24
Acquisition 25
Sinocare Acquires Nipro Diagnostics from Nipro 25
Nipro to Acquire Infraredx 26
Cordis Acquires Flexible Stenting Solutions 27
Nipro Acquires MGlas And MG Sterile Products For US$34 Million 29
Nipro Acquires 55% Stake In Tube Glass Containers From Arch Impex 30
Flexible Stenting Solutions Receives Investment From Goodman 31
Nipro Corp – Key Competitors 32
Nipro Corp – Key Employees 33
Nipro Corp – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Joint Venture 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Nipro Corp, Medical Equipment, Key Facts, 2017 2
Nipro Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Nipro Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Nipro Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Nipro Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Nipro Corp, Deals By Market, 2011 to YTD 2017 8
Nipro Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Nipro Invests US$25 Million In Infraredx 10
InfraReDx Secures US$24.1 Million In Financing 11
Biocept Raises Funds In Growth Equity Financing Round 12
Rontis Enters into Distribution Agreement with Nipro Medical 13
Infraredx Enters into R&D Agreement with Massachusetts General Hospital 14
Koninklijke Royal Philips And Infraredx Enter Into Agreement For Imaging System And X-ray Systems 15
Infraredx Enters Into Co-Development Agreement With Philips 16
Infraredx Enters Into Distribution Agreement With Nipro For TVC Imaging System 17
Nipro To Form A Joint Venture With Freesom Holdings 18
Infraredx Withdraws IPO 19
Biocept Raises USD2 Million in Private Placement of Series A Preferred Stock 20
Nipro Completes Public Offering Of Shares For US$266 Million 21
Nipro Prices Private Placement Of Shares For US$31 Million 22
Nipro Announces Private Placement Of Convertible Bonds For US$85.5 Million 23
NIPRO Completes Private Placement Of Eights Series Unsecured Straight Bonds For US$244 Million 24
Sinocare Acquires Nipro Diagnostics from Nipro 25
Nipro to Acquire Infraredx 26
Cordis Acquires Flexible Stenting Solutions 27
Nipro Acquires MGlas And MG Sterile Products For US$34 Million 29
Nipro Acquires 55% Stake In Tube Glass Containers From Arch Impex 30
Flexible Stenting Solutions Receives Investment From Goodman 31
Nipro Corp, Key Competitors 32
Nipro Corp, Key Employees 33
Nipro Corp, Other Locations 34
Nipro Corp, Subsidiaries 34
Nipro Corp, Joint Venture 36

★海外企業調査レポート[Nipro Corp (8086)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Debiotech SA-医療機器分野:企業M&A・提携分析
    Summary Debiotech SA (Debiotech) is a medical device company that develops therapeutic devices and diagnostic products. The company’s products include patch-pump, injection, multi-fluidic cassette type system, infusion pump and microsystems. It develops products in the areas of implantable and exter …
  • BioMedomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioMedomics Inc (BioMedomics) is a point-of-care diagnostics company that develops and markets immunologically-based disease-specific tests and advanced highly sensitive quantitative platforms. The company provides technologies such as time-resolved lateral flow immunoassay and nanotube base …
  • KPMG International:企業の戦略・SWOT・財務情報
    KPMG International - Strategy, SWOT and Corporate Finance Report Summary KPMG International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • PTT Global Chemical Public Co Ltd (PTTGC):企業の財務・戦略的SWOT分析
    PTT Global Chemical Public Co Ltd (PTTGC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Commonwealth Scientific and Industrial Research Organisation-製薬・医療分野:企業M&A・提携分析
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • HollyFrontier Corporation (HFC)-石油・ガス分野:企業M&A・提携分析
    Summary HollyFrontier Corporation (HollyFrontier) is an independent energy company. It carries out crude oil refining and wholesale marketing of refined petroleum products. The company produces and markets high-value light products such as gasoline, diesel, jet fuel, specialty lubricant products, he …
  • Lite-On Technology Corp (2301):企業の財務・戦略的SWOT分析
    Lite-On Technology Corp (2301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Yamaha Corporation:企業の戦略・SWOT・財務分析
    Yamaha Corporation - Strategy, SWOT and Corporate Finance Report Summary Yamaha Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • bitop AG-医療機器分野:企業M&A・提携分析
    Summary Bitop AG (bitop) is a developer, manufacturer and marketer of cosmetic ingredients. The company offers extremolytes, medical devices, cosmetic ingredients and bio-stabilizer products. It offers medical devices for dermatology, allergy, cough and cold; airway diseases and dry epithelia applic …
  • Choppies Enterprises Limited:企業の戦略的SWOT分析
    Choppies Enterprises Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • PowerFilm, Inc.:企業の戦略的SWOT分析
    PowerFilm, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Distil plc:企業の戦略・SWOT・財務情報
    Distil plc - Strategy, SWOT and Corporate Finance Report Summary Distil plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Brokk AB:企業の戦略的SWOT分析
    Brokk AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Avadel Pharmaceuticals Plc (AVDL):企業の財務・戦略的SWOT分析
    Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Zosano Pharma Corp (ZSAN):企業の財務・戦略的SWOT分析
    Summary Zosano Pharma Corp (Zosano Pharma), formerly ZP Holdings Inc, is a clinical stage biopharmaceutical company that develops proprietary transdermal delivery system. The company develops a transdermal microneedle patch system to deliver its drug formulations through the skin for the treatment o …
  • Bank Leumi (UK) plc:企業の戦略的SWOT分析
    Bank Leumi (UK) plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Aldi Einkauf GmbH & Co oHG:企業の戦略・SWOT・財務情報
    Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report Summary Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Genomind Inc-医療機器分野:企業M&A・提携分析
    Summary Genomind Inc (Genomind) is a personalized medicine company that provides genetic testing products. The company’s product portfolio includes The Genecept Assay, a genetic test developed for clinicians to optimize treatment decisions for their patients with mental illness. Its assay finds pati …
  • Oxford Biodynamics Plc-製薬・医療分野:企業M&A・提携分析
    Summary Oxford Biodynamics Plc (Oxford Biodynamics) is a biotechnology company that discovers and develops biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, …
  • Covance Inc-製薬・医療分野:企業M&A・提携分析
    Summary Covance Inc (Covance), a subsidiary of LabCorp, is a drug development company that offers contract research and manufacturing services. The company offers a broad range of early-stage and late-stage product development services to pharmaceutical, biotechnology and medical device companies. I …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆